Global Integrated Intelligent Toilet Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Integrated Intelligent Toilet

This report studies Integrated Intelligent Toilet in Global market, especially in NORTH AMERICA, EUROPE, China, Japan, Korea and ROW, focuses on top players in these countries, with sales, price, revenue and market share in Global market, like

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/738996-global-integrated-intelligent-toilet-market-research-report-2015-to-2021

Panasonic
TOTO
MOPO
INAX
Roca
HCG
DURAVIT
NOVITA
KOHLER
BJB
JOMOO
VIVI
HOROW
DGPOSY
American Standard
FAENZA
ARROW
ORANS
SSWW
DONGPENG

Market Segment by Regions, this report splits Global into several key countries, with sales (consumption), revenue, market share and growth rate of Integrated Intelligent Toilet in these countries, from 2011 to 2021 (forecast), like

NORTH AMERICA
China
EUROPE
Japan
Korea
ROW
Rest of Global

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Would like to place an order @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=738996

Wash-down Toilet
Siphon Toilet

Split by applications, this report focuses on consumption, market share and growth rate of Integrated Intelligent Toilet in each application, can be divided into

300 Toilet pit
400 Toilet pit
Tailor-made Toilet pit

With 120 pages, 150 charts and seven chapters, to display the market present situation and future, clearly and deeply.
Table of Contents:

Global Integrated Intelligent Toilet Market Research Report 2015 to 2021

1 Integrated Intelligent Toilet Overview

1.1 Product Overview and Scope of Integrated Intelligent Toilet

1.2 Integrated Intelligent Toilet Segment by Type

1.2.1 Wash-down Toilet and Sales Growth Rate 2011-2021

1.2.2 Siphon Toilet and Sales Growth Rate 2011-2021

1.3 Integrated Intelligent Toilet Segment by Applications

1.3.1 Integrated Intelligent Toilet Sales Market Share by Applications in 2015 and 2016

1.3.2 300 Toilet pit and Key Clients (Buyers) List

1.3.3 400 Toilet pit and Key Clients (Buyers) List

1.3.4 Tailor-made Toilet pit and Key Clients (Buyers) List

1.4 Integrated Intelligent Toilet Market by Regions

1.4.1 NORTH AMERICA Status and Prospect 2011-2021

1.4.2 China Status and Prospect 2011-2021

1.4.3 EUROPE Status and Prospect 2011-2021

1.4.4 Japan Status and Prospect 2011-2021

1.4.5 Korea Status and Prospect 2011-2021

1.4.6 ROW Status and Prospect 2011-2021

1.5 Global Market Size (Value and Volume) of Integrated Intelligent Toilet 2011-2021

1.5.1 Global Integrated Intelligent Toilet Sales and Growth Rate 2011-2021

1.5.2 Global Integrated Intelligent Toilet Revenue and Growth Rate 2011-2021

2 Global Integrated Intelligent Toilet Market Competition by Manufacturers

2.1 Global Integrated Intelligent Toilet Sales and Share by Manufacturers (2015 and 2016)

2.2 Global Integrated Intelligent Toilet Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Integrated Intelligent Toilet Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Integrated Intelligent Toilet Manufacturing Base Distribution and Product Type

3 Global Integrated Intelligent Toilet Market Analysis by Type and Applications

3.1 Global Integrated Intelligent Toilet Sales, Market Share and Growth Rate by Type 2011-2021

3.2 Global Integrated Intelligent Toilet Revenue, Market Share and Growth Rate by Type 2011-2021

3.3 Integrated Intelligent Toilet Average Price by Type in 2015

3.4 Global Integrated Intelligent Toilet Sales, Market Share and Growth Rate by Applications 2011-2021

4 Global Integrated Intelligent Toilet Manufacturers Analysis

4.1 Panasonic

4.1.1 Company Basic Information, Manufacturing Base and Competitors

4.1.2 Integrated Intelligent Toilet Product Type and Technology

4.1.2.1 Wash-down Toilet Price and Specification

4.1.2.2 Siphon Toilet Price and Specification

4.1.3 Integrated Intelligent Toilet Sales, Revenue, Price of Panasonic 2015 to 2016

4.2 TOTO

4.2.1 Company Basic Information, Manufacturing Base and Competitors

4.2.2 Integrated Intelligent Toilet Product Type and Technology

4.2.2.1 Wash-down Toilet Price and Specification

4.2.2.2 Siphon Toilet Price and Specification

4.2.3 Integrated Intelligent Toilet Sales, Revenue, Price of TOTO 2015 to 2016

4.3 MOPO

4.3.1 Company Basic Information, Manufacturing Base and Competitors

4.3.2 Integrated Intelligent Toilet Product Type and Technology

4.3.2.1 Wash-down Toilet Price and Specification

4.3.2.2 Siphon Toilet Price and Specification

4.3.3 Integrated Intelligent Toilet Sales, Revenue, Price of MOPO 2015 to 2016

4.4 INAX

4.4.1 Company Basic Information, Manufacturing Base and Competitors

4.4.2 Integrated Intelligent Toilet Product Type and Technology

4.4.2.1 Wash-down Toilet Price and Specification

4.4.2.2 Siphon Toilet Price and Specification

4.4.3 Integrated Intelligent Toilet Sales, Revenue, Price of INAX 2015 to 2016

4.5 Roca

4.5.1 Company Basic Information, Manufacturing Base and Competitors

4.5.2 Integrated Intelligent Toilet Product Type and Technology

4.5.2.1 Wash-down Toilet Price and Specification

4.5.2.2 Siphon Toilet Price and Specification

4.5.3 Integrated Intelligent Toilet Sales, Revenue, Price of Roca 2015 to 2016

4.6 HCG

4.6.1 Company Basic Information, Manufacturing Base and Competitors

4.6.2 Integrated Intelligent Toilet Product Type and Technology

4.6.2.1 Wash-down Toilet Price and Specification

4.6.2.2 Siphon Toilet Price and Specification

4.6.3 Integrated Intelligent Toilet Sales, Revenue, Price of HCG 2015 to 2016

4.7 DURAVIT

4.7.1 Company Basic Information, Manufacturing Base and Competitors

4.7.2 Integrated Intelligent Toilet Product Type and Technology

4.7.2.1 Wash-down Toilet Price and Specification

4.7.2.2 Siphon Toilet Price and Specification

4.7.3 Integrated Intelligent Toilet Sales, Revenue, Price of DURAVIT 2015 to 2016

4.8 NOVITA

4.8.1 Company Basic Information, Manufacturing Base and Competitors

4.8.2 Integrated Intelligent Toilet Product Type and Technology

4.8.2.1 Wash-down Toilet Price and Specification

4.8.2.2 Siphon Toilet Price and Specification

4.8.3 Integrated Intelligent Toilet Sales, Revenue, Price of NOVITA 2015 to 2016

4.9 KOHLER

4.9.1 Company Basic Information, Manufacturing Base and Competitors

4.9.2 Integrated Intelligent Toilet Product Type and Technology

4.9.2.1 Wash-down Toilet Price and Specification

4.9.2.2 Siphon Toilet Price and Specification

4.9.3 Integrated Intelligent Toilet Sales, Revenue, Price of KOHLER 2015 to 2016

4.10 BJB

4.10.1 Company Basic Information, Manufacturing Base and Competitors

4.10.2 Integrated Intelligent Toilet Product Type and Technology

4.10.2.1 Wash-down Toilet Price and Specification

4.10.2.2 Siphon Toilet Price and Specification

4.10.3 Integrated Intelligent Toilet Sales, Revenue, Price of BJB 2015 to 2016

4.11 JOMOO

4.12 VIVI

4.13 HOROW

4.14 DGPOSY

4.15 American Standard

4.16 FAENZA

4.17 ARROW

4.18 ORANS

4.19 SSWW

4.20 DONGPENG

5 Global Integrated Intelligent Toilet Market Analysis by Regions

5.1 NORTH AMERICA Integrated Intelligent Toilet Market

5.1.1 NORTH AMERICA Integrated Intelligent Toilet Sales, Revenue and Growth Rate 2011-2021

Access Complete Report@ https://www.wiseguyreports.com/reports/738996-global-integrated-intelligent-toilet-market-research-report-2015-to-2021

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Type 2 Diabetes Therapeutic and Overview Pipeline Review H2

Type 2 Diabetes Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — Type 2 diabetes is a chronic condition and is the most common form of diabetes. High levels of glucose are a characteristic feature. The body might become resistant to insulin or may not produce enough amounts. Due to abnormal insulin functioning, glucose is concentrated in the blood leading to elevated levels and hence causing type 2 diabetes. Symptoms include fatigue, weight issues, vision deficits and various other effects. Risk factors include family history, age, obesity, physical inactivity and high blood pressure. This condition is handled by lifestyle alterations and regular medications.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740544-type-2-diabetes-pipeline-review-h2-2016

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Type 2 Diabetes (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Type 2 Diabetes (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Type 2 Diabetes and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 18, 25, 71, 54, 6, 252, 85 and 7 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 66 and 20 molecules, respectively.Type 2 Diabetes.

Type 2 Diabetes (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Type 2 Diabetes (Metabolic Disorders).
– The pipeline guide reviews pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Type 2 Diabetes (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Type 2 Diabetes (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Type 2 Diabetes (Metabolic Disorders)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Type 2 Diabetes (Metabolic Disorders).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Type 2 Diabetes (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents
Table of Contents 2
Introduction 12
Type 2 Diabetes Overview 13
Therapeutics Development 14
Type 2 Diabetes – Therapeutics under Development by Companies 16
Type 2 Diabetes – Therapeutics under Investigation by Universities/Institutes 36
Type 2 Diabetes – Pipeline Products Glance 40
Type 2 Diabetes – Products under Development by Companies 44
Type 2 Diabetes – Products under Investigation by Universities/Institutes 78
Type 2 Diabetes – Companies Involved in Therapeutics Development 84
Type 2 Diabetes – Therapeutics Assessment 313
Drug Profiles 368
Type 2 Diabetes – Dormant Projects 1156
Type 2 Diabetes – Discontinued Products 1204
Type 2 Diabetes – Product Development Milestones 1223

Access Report @ https://www.wiseguyreports.com/reports/740544-type-2-diabetes-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Smart Irrigation Market Share,Supply And Consumption 2016 To 2021 Market Research Report



Wise.Guy.

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ —

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/557327-global-smart-irrigation-market-research-report-to-2020

This report studies Smart Irrigation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering
Rain Bird Corporation
The Toro Company
Hunter Industries
Netafim
Hydropoint Data Systems
Baseline Inc.
Calsense
Galcon
Rachio Inc.
Weathermatic

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Smart Irrigation in these regions, from 2011 to 2020 (forecast), like
North America
China
Europe
Japan
India
Southeast Asia

Split by product types, with production, revenue, price, market share and growth rate of each type, can be divided into
Weather-based controller
Sensor-based controller
Type 3

Split by applications, this report focuses on consumption, market share and growth rate of Smart Irrigation in each application, can be divided into
Agriculture
Non-agriculture
Application 3

Complete Report Details @ https://www.wiseguyreports.com/reports/557327-global-smart-irrigation-market-research-report-to-2020

Table of Contents

Global Smart Irrigation Market Research Report 2021

1 Smart Irrigation Overview
1.1 Product Overview and Scope of Smart Irrigation
1.2 Smart Irrigation Segment by Types
1.2.1 Global Production Market Share of Smart Irrigation by Types in 2015
1.2.2 Weather-based controller Overview and Price
1.2.2.1 Weather-based controller Overview
1.2.2.2 Weather-based controller Growth Rate
1.2.3 Sensor-based controller
1.2.3.1 Sensor-based controller Overview
1.2.3.2 Sensor-based controller Growth Rate
1.2.4 Type 3
1.2.4.1 Type 1 Overview
1.2.4.2 Type 2 Growth Rate
1.3 Smart Irrigation Segment by Applications
1.3.1 Smart Irrigation Consumption Market Share by Applications in 2015
1.3.2 Agriculture and Major Clients (Buyers) List
1.3.3 Non-agriculture and Major Clients (Buyers) List
1.3.4 Application 3 and Major Clients (Buyers) List
1.4 Smart Irrigation Market by Regions
1.4.1 North America Status and Prospect (2011-2020)
1.4.2 China Status and Prospect (2011-2020)
1.4.3 Europe Status and Prospect (2011-2020)
1.4.4 Japan Status and Prospect (2011-2020)
1.4.5 India Status and Prospect (2011-2020)
1.4.6 Southeast Asia Status and Prospect (2011-2020)
1.5 Global Market Size (Value and Volume) of Smart Irrigation (2011-2020)
1.5.1 Global Smart Irrigation Sales and Revenue (2011-2020)
1.5.2 Global Smart Irrigation Sales and Growth Rate (2011-2020)
1.5.3 Global Smart Irrigation Revenue and Growth Rate (2011-2020)

2 Global Smart Irrigation Market Competition by Manufacturers
2.1 Global Smart Irrigation Production and Share by Manufacturers (2015 and 2016)
2.2 Global Smart Irrigation Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Smart Irrigation Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Smart Irrigation Manufacturing Base Distribution and Product Types
2.5 Competitive Situation and Trends
2.5.1 Expansions
2.5.2 New Product Launches
2.5.3 Acquisitions
2.5.4 Other Developments

3 Global Smart Irrigation Analysis by Regions
3.1 Global Smart Irrigation Production, Revenue and Market Share by Regions (2011-2020)
3.1.1 Global Smart Irrigation Production Market Share by Regions (2011-2020)
3.1.2 Global Smart Irrigation Revenue Market Share by Regions (2011-2020)
3.2 Global Smart Irrigation Consumption by Regions (2011-2020)
3.3 North America
3.3.1 North America Smart Irrigation Production, Revenue and Price (2011-2020)
3.3.2 North America Smart Irrigation Production, Revenue and Growth Rate (2011-2020)
3.4 Europe
3.4.1 Europe Smart Irrigation Production, Revenue and Price (2011-2020)
3.4.2 Europe Smart Irrigation Production, Revenue and Growth Rate (2011-2020)
3.5 China
3.5.1 China Smart Irrigation Production, Revenue and Price (2011-2020)
3.5.2 China Smart Irrigation Production, Revenue and Growth Rate (2011-2020)
3.6 Japan
3.6.1 Japan Smart Irrigation Production, Revenue and Price (2011-2020)
3.6.2 Japan Smart Irrigation Production, Revenue and Growth Rate (2011-2020)
3.7 India
3.7.1 India Smart Irrigation Production, Revenue and Price (2011-2020)
3.7.2 India Smart Irrigation Production, Revenue and Growth Rate (2011-2020)
3.8 Southeast Asia
3.8.1 Southeast Asia Smart Irrigation Production, Revenue and Price (2011-2020)
3.8.2 Southeast Asia Smart Irrigation Production, Revenue and Growth Rate (2011-2020)

4 Global Smart Irrigation Analysis by Types
4.1 Global Smart Irrigation Production, Revenue, Market Share and Growth Rate by Types (2011-2020)
4.1.1 Global Smart Irrigation Production and Market Share by Types (2011-2020)
4.1.2 Global Smart Irrigation Revenue, Market Share and Growth Rate by Types (2011-2020)
4.2 Weather-based controller Production, Revenue, Price and Growth (2011-2020)
4.3 Sensor-based controller Production, Revenue, Price and Growth (2011-2020)
4.4 Type 3 Production, Revenue, Price and Growth (2011-2020)

……….

6 Global Smart Irrigation Manufacturers Analysis
6.1 Rain Bird Corporation
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Smart Irrigation Product Types and Technology
6.1.2.1 Weather-based controller
6.1.2.2 Sensor-based controller
6.1.2.3 Type 3
6.1.3 Rain Bird Corporation Capacity, Revenue, Price of Smart Irrigation (2015 and 2016)
6.2 The Toro Company
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Smart Irrigation Product Types and Technology
6.2.2.1 Weather-based controller
6.2.2.2 Sensor-based controller
6.2.2.3 Type 3
6.2.3 The Toro Company Production, Revenue, Price of Smart Irrigation (2015 and 2016)
6.3 Hunter Industries
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Smart Irrigation Product Types and Technology
6.3.2.1 Weather-based controller
6.3.2.2 Sensor-based controller
6.3.2.3 Type 3
6.3.3 Hunter Industries Capacity, Revenue, Price of Smart Irrigation (2015 and 2016)
6.4 Netafim
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Smart Irrigation Product Types and Technology
6.4.2.1 Weather-based controller
6.4.2.2 Sensor-based controller

…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=557327

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

GP Pharm Therapeutic and Overview Pipeline Review H2



Wise.Guy.

GP Pharm Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by GP Pharm, S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740540-gp-pharm-s-a-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of GP Pharm, S.A.
– The report provides overview of GP Pharm, S.A. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses GP Pharm, S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features GP Pharm, S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate GP Pharm, S.A.’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for GP Pharm, S.A.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding GP Pharm, S.A.’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
GP Pharm, S.A. Snapshot 4
GP Pharm, S.A. Overview 4
Key Facts 4
GP Pharm, S.A. – Research and Development Overview 5
Key Therapeutic Areas 5
GP Pharm, S.A. – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
GP Pharm, S.A. – Pipeline Products Glance 9
GP Pharm, S.A. – Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
GP Pharm, S.A. – Drug Profiles 10
leuprolide acetate – Drug Profile 10
Product Description 10
Mechanism Of Action 10
R&D Progress 10
octreotide acetate MAR – Drug Profile 11
Product Description 11
Mechanism Of Action 11
R&D Progress 11
Pegylated Doxorubicin – Drug Profile 12
Product Description 12
Mechanism Of Action 12
R&D Progress 12
risperidone depot – Drug Profile 13
Product Description 13
Mechanism Of Action 13
R&D Progress 13
GP Pharm, S.A. – Pipeline Analysis 14
GP Pharm, S.A. – Pipeline Products by Target 14
GP Pharm, S.A. – Pipeline Products by Route of Administration 15
GP Pharm, S.A. – Pipeline Products by Molecule Type 16
GP Pharm, S.A. – Pipeline Products by Mechanism of Action 17
GP Pharm, S.A. – Dormant Projects 18
GP Pharm, S.A. – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21

Access Report @ https://www.wiseguyreports.com/reports/740540-gp-pharm-s-a-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Car Air Purifier Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report studies Car Air Purifier in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India

PUNE, MAHARASTRA, INDIA, November 14, 2016 /EINPresswire.com/ —

Summary

This report studies Car Air Purifier in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Philips
Sharp
Panasonic
Agcen
VOSSON
YADU
Purafil

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/739393-global-car-air-purifier-market-professional-survey-report-2016

By types, the market can be split into
Type I
Type II
Type III

By Application, the market can be split into
Application 1
Application 2
Application 3

By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India

At any Query @ https://www.wiseguyreports.com/enquiry/739393-global-car-air-purifier-market-professional-survey-report-2016

Table of Contents

Global Car Air Purifier Market Professional Survey Report 2016
1 Industry Overview of Car Air Purifier
1.1 Definition and Specifications of Car Air Purifier
1.1.1 Definition of Car Air Purifier
1.1.2 Specifications of Car Air Purifier
1.2 Classification of Car Air Purifier
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Applications of Car Air Purifier
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India

8 Major Manufacturers Analysis of Car Air Purifier
8.1 Philips
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Philips 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Philips 2015 Car Air Purifier Business Region Distribution Analysis
8.2 Sharp
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Sharp 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Sharp 2015 Car Air Purifier Business Region Distribution Analysis
8.3 Panasonic
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Panasonic 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Panasonic 2015 Car Air Purifier Business Region Distribution Analysis
8.4 Agcen
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Agcen 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Agcen 2015 Car Air Purifier Business Region Distribution Analysis
8.5 VOSSON
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 VOSSON 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 VOSSON 2015 Car Air Purifier Business Region Distribution Analysis
8.6 YADU
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 YADU 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 YADU 2015 Car Air Purifier Business Region Distribution Analysis
8.7 Purafil
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Purafil 2015 Car Air Purifier Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Purafil 2015 Car Air Purifier Business Region Distribution Analysis

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=739393

…..Continued

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Akshaya Bio Inc. Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Akshaya Bio Inc. Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Akshaya Bio Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740537-akshaya-bio-inc-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of Akshaya Bio Inc.
– The report provides overview of Akshaya Bio Inc. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Akshaya Bio Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Akshaya Bio Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Akshaya Bio Inc.’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Akshaya Bio Inc.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Akshaya Bio Inc.’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Akshaya Bio Inc. Snapshot 5
Akshaya Bio Inc. Overview 5
Key Facts 5
Akshaya Bio Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Akshaya Bio Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Pipeline Products – Combination Treatment Modalities 10
Akshaya Bio Inc. – Pipeline Products Glance 11
Akshaya Bio Inc. – Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Akshaya Bio Inc. – Drug Profiles 13
hepatitis C vaccine – Drug Profile 13
Product Description 13
Mechanism Of Action 13
R&D Progress 13
HIV vaccine – Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
influenza [strains A/H5N1 + A/H1N1] vaccine – Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
malaria vaccine – Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
NU-500 – Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Vaccine to Target CA9 for Cancer – Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
Vaccine to Target CEA for Oncology – Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Vaccine to Target HER 2/neu for Cancer – Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Vaccine to Target MUC1 for Oncology – Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Vaccine to Target PAP for Prostate Cancer – Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Westrern Equine Encephalitis Virus Vaccine – Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
Akshaya Bio Inc. – Pipeline Analysis 24
Akshaya Bio Inc. – Pipeline Products by Target 24
Akshaya Bio Inc. – Pipeline Products by Molecule Type 26
Akshaya Bio Inc. – Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28

Access Report @ https://www.wiseguyreports.com/reports/740537-akshaya-bio-inc-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Noxxon Pharma AG Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Noxxon Pharma AG Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Noxxon Pharma AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740533-noxxon-pharma-ag-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of Noxxon Pharma AG
– The report provides overview of Noxxon Pharma AG including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Noxxon Pharma AG’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Noxxon Pharma AG’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Noxxon Pharma AG’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Noxxon Pharma AG
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Noxxon Pharma AG’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Noxxon Pharma AG Snapshot 5
Noxxon Pharma AG Overview 5
Key Facts 5
Noxxon Pharma AG – Research and Development Overview 6
Key Therapeutic Areas 6
Noxxon Pharma AG – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Noxxon Pharma AG – Pipeline Products Glance 11
Noxxon Pharma AG – Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Noxxon Pharma AG – Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Noxxon Pharma AG – Drug Profiles 14
emapticap pegol – Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
lexaptepid pegol – Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
NOXD-19 – Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
NOXD-20 – Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
NOXD-21 – Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
NOXG-15 – Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
NOXG-16 – Drug Profile 23
Product Description 23
Mechanism Of Action 23
R&D Progress 23
NOXL-41 – Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
NOXS-93 – Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
olaptesed pegol – Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
Noxxon Pharma AG – Pipeline Analysis 29

Access Report @ https://www.wiseguyreports.com/reports/740533-noxxon-pharma-ag-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Automotive safety system market 2016:size, share, demand, trends, growth and 2021 forecasts

This report studies Automotive safety system in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India

PUNE, MAHARASTRA, INDIA, November 14, 2016 /EINPresswire.com/ — Summary

This report studies Automotive safety system in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Continental AG
Delphi Automotive PLC
TRW Automotive Holdings Corp.
Autoliv Inc.
Toyoda Gosei Co.
WABCO Holdings Inc.
Infineon Technologies AG
Eaton Corp.
Clarion Corp. of America

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/739391-global-automotive-safety-system-market-research-report-2016

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Automotive safety system in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Gasoline Automotive
Diesel Automotive
Hybrid Automotive
Flex Fuel Automotive
Other
Split by application, this report focuses on consumption, market share and growth rate of Automotive safety system in each application, can be divided into
Passenger Car
Commercial Vehicle
Other

At any Query @ https://www.wiseguyreports.com/enquiry/739391-global-automotive-safety-system-market-research-report-2016

Table of Contents

Global Automotive safety system Market Research Report 2016
1 Automotive safety system Market Overview
1.1 Product Overview and Scope of Automotive safety system
1.2 Automotive safety system Segment by Type
1.2.1 Global Production Market Share of Automotive safety system by Type in 2015
1.2.2 Gasoline Automotive
1.2.3 Diesel Automotive
1.2.4 Hybrid Automotive
1.2.5 Flex Fuel Automotive
1.2.6 Other
1.3 Automotive safety system Segment by Application
1.3.1 Automotive safety system Consumption Market Share by Application in 2015
1.3.2 Passenger Car
1.3.3 Commercial Vehicle
1.3.4 Other
1.4 Automotive safety system Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Automotive safety system (2011-2021)

7 Global Automotive safety system Manufacturers Profiles/Analysis
7.1 Continental AG
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Automotive safety system Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Continental AG Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Delphi Automotive PLC
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Automotive safety system Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Delphi Automotive PLC Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 TRW Automotive Holdings Corp.
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Automotive safety system Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 TRW Automotive Holdings Corp. Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Autoliv Inc.
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Automotive safety system Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Autoliv Inc. Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Toyoda Gosei Co.
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Automotive safety system Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Toyoda Gosei Co. Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 WABCO Holdings Inc.
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Automotive safety system Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 WABCO Holdings Inc. Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Infineon Technologies AG
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Automotive safety system Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Infineon Technologies AG Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Eaton Corp.
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Automotive safety system Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Eaton Corp. Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Clarion Corp. of America
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Automotive safety system Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Clarion Corp. of America Automotive safety system Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=739391

…..Continued

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Mitsubishi Tanabe Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Mitsubishi Tanabe Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Mitsubishi Tanabe Pharma Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740532-mitsubishi-tanabe-pharma-corporation-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of Mitsubishi Tanabe Pharma Corporation
– The report provides overview of Mitsubishi Tanabe Pharma Corporation including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Mitsubishi Tanabe Pharma Corporation’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Mitsubishi Tanabe Pharma Corporation’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Mitsubishi Tanabe Pharma Corporation’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Mitsubishi Tanabe Pharma Corporation
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Mitsubishi Tanabe Pharma Corporation’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 7
Mitsubishi Tanabe Pharma Corporation Snapshot 8
Mitsubishi Tanabe Pharma Corporation Overview 8
Key Facts 8
Mitsubishi Tanabe Pharma Corporation – Research and Development Overview 9
Key Therapeutic Areas 9
Mitsubishi Tanabe Pharma Corporation – Pipeline Review 13
Pipeline Products by Stage of Development 13
Pipeline Products – Monotherapy 14
Pipeline Products – Combination Treatment Modalities 15
Pipeline Products – Partnered Products 16
Partnered Products/Combination Treatment Modalities 17
Pipeline Products – Out-Licensed Products 18
Out-Licensed Products/Combination Treatment Modalities 19
Mitsubishi Tanabe Pharma Corporation – Pipeline Products Glance 20
Mitsubishi Tanabe Pharma Corporation – Late Stage Pipeline Products 20
Pre-Registration Products/Combination Treatment Modalities 20
Phase III Products/Combination Treatment Modalities 21
Mitsubishi Tanabe Pharma Corporation – Clinical Stage Pipeline Products 22
Phase II Products/Combination Treatment Modalities 22
Phase I Products/Combination Treatment Modalities 23
Mitsubishi Tanabe Pharma Corporation – Early Stage Pipeline Products 24
IND/CTA Filed Products/Combination Treatment Modalities 24
Preclinical Products/Combination Treatment Modalities 25
Discovery Products/Combination Treatment Modalities 26
Mitsubishi Tanabe Pharma Corporation – Drug Profiles 27
(canagliflozin + teneligliptin) – Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
amiselimod hydrochloride – Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
avanafil – Drug Profile 30
Product Description 30
Mechanism Of Action 30
R&D Progress 30
bepotastine besylate – Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
canagliflozin – Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
cariprazine – Drug Profile 40
Product Description 40
Mechanism Of Action 40

Access Report @ https://www.wiseguyreports.com/reports/740532-mitsubishi-tanabe-pharma-corporation-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

LG Life Science LTD. Therapeutic and Overview Pipeline Review H2



Wise.Guy.

LG Life Science LTD. Treatment Pipeline Review H2 2016

PUNE, INDIA, November 14, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by LG Life Science LTD., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/740529-lg-life-science-ltd-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of LG Life Science LTD.
– The report provides overview of LG Life Science LTD. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses LG Life Science LTD.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features LG Life Science LTD.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate LG Life Science LTD.’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for LG Life Science LTD.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding LG Life Science LTD.’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 6
LG Life Science LTD. Snapshot 7
LG Life Science LTD. Overview 7
Key Facts 7
LG Life Science LTD. – Research and Development Overview 8
Key Therapeutic Areas 8
LG Life Science LTD. – Pipeline Review 12
Pipeline Products by Stage of Development 12
Pipeline Products – Monotherapy 13
Pipeline Products – Combination Treatment Modalities 14
Pipeline Products – Partnered Products 15
Partnered Products/Combination Treatment Modalities 16
Pipeline Products – Out-Licensed Products 17
Out-Licensed Products/Combination Treatment Modalities 18
LG Life Science LTD. – Pipeline Products Glance 19
LG Life Science LTD. – Late Stage Pipeline Products 19
Pre-Registration Products/Combination Treatment Modalities 19
Phase III Products/Combination Treatment Modalities 20
LG Life Science LTD. – Clinical Stage Pipeline Products 21
Phase II Products/Combination Treatment Modalities 21
Phase I Products/Combination Treatment Modalities 22
LG Life Science LTD. – Early Stage Pipeline Products 23
Preclinical Products/Combination Treatment Modalities 23
Discovery Products/Combination Treatment Modalities 24
LG Life Science LTD. – Unknown Stage Pipeline Products 25
Unknown Products/Combination Treatment Modalities 25
LG Life Science LTD. – Drug Profiles 26
(gemigliptin + glimepiride) – Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
(gemigliptin + metformin hydrochloride) – Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
(gemigliptin + rosuvastatin calcium) – Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
(lercanidipine hydrochloride + valsartan) – Drug Profile 29
Product Description 29
Mechanism Of Action 29
R&D Progress 29
adalimumab biosimilar – Drug Profile 30
Product Description 30

Access Report @ https://www.wiseguyreports.com/reports/740529-lg-life-science-ltd-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR